ImmunityBio, Inc. — Director's Dealing 2015

Jul 27, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2015-07-27

Reporting Person: Ji Henry (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.0001 per share	776535	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$1.9984	2025-01-16	Common Stock (370300)		Direct
Stock Option (Right to Buy)	$1.9984	2025-02-16	Common Stock (481390)		Indirect

Footnotes

F1: Represents shares held by an entity of which the Reporting Person's spouse is the sole managing member. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2: One twenty-fourth of the shares subject to the option shall vest on the date that is one month from January 16, 2015 and an additional one twenty-fourth shall vest on the same day of each subsequent month, in each case subject to the Reporting Person's continued status as a service provider with the Issuer.

F3: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.